Helen of Troy
This article was originally published in The Rose Sheet
Executive Summary
Increased focus on wholesale business within personal products segment has "stabilized or at least created a core business in Tactica and left us with less volatility," Senior VP, Chief Financial Officer Russell Gibson tells analysts Oct. 10. Wholesale advances in Tactica, which markets Epil-Stop and IGIA brands, were offset by significant drop in direct response sales, leading to 35% decline in overall division revenue in fiscal second quarter ended Aug. 31, exec notes. Drop was "almost entirely attributable" to reduced sales of Epil-Stop in direct response channel, Gibson says. Firm's consolidated sales fell 1.4% to $111 mil. in Q2, while net income jumped 22% to $8.9 mil. due to cost control initiatives. Full "ramp up" of Clairol brands to be acquired through agreement with P&G will take at least six months, company states. Completion of deal, which covers six hair and skin care brands, is expected within 90 days (1"The Rose Sheet" Sept. 30, 2002, p. 3)...
You may also be interested in...
Helen Of Troy Personal Product Sales To Top $150 Mil. With Clairol Brands
Hair and body care appliance marketer Helen of Troy will build its personal product sales to over $150 mil. with the acquisition of six hair and skin care brands from Procter & Gamble that were previously owned by Clairol
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.